Michele Robertson Selected Research

Michele Robertson Research Topics

Disease

18	Heart Failure 01/2021 - 10/2007
12	Myocardial Infarction 12/2021 - 02/2005
12	Stroke (Strokes) 11/2021 - 02/2009
9	Coronary Disease (Coronary Heart Disease) 11/2017 - 09/2008
8	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 09/2008
7	Vascular Diseases (Vascular Disease) 11/2017 - 11/2005
7	Left Ventricular Dysfunction 12/2015 - 02/2005
6	Systolic Heart Failure 02/2016 - 05/2012
4	Heart Diseases (Heart Disease) 07/2014 - 05/2010
3	Atrial Fibrillation 01/2021 - 02/2005
3	Coronary Artery Disease (Coronary Atherosclerosis) 08/2013 - 10/2009
2	Peripheral Arterial Disease 01/2021 - 12/2015
2	Infections 01/2020 - 01/2011
2	Ischemic Stroke 01/2016 - 02/2009
2	Diabetes Mellitus 12/2015 - 02/2009
2	Bundle-Branch Block (Fascicular Block) 04/2015 - 09/2013
2	Thrombosis (Thrombus) 02/2011 - 03/2010
2	Inflammation (Inflammations) 02/2011 - 03/2010
2	Infarction (Infarctions) 10/2007 - 02/2005
1	Renal Insufficiency (Renal Failure) 11/2021
1	Gout 11/2020
1	Acute Coronary Syndrome 11/2020
1	Arteriovenous Fistula 01/2020
1	Fistula 01/2020
1	Nausea 01/2016
1	Hypertension (High Blood Pressure) 12/2015
1	Anemia 12/2015
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2015
1	Bradycardia 09/2013
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2012
1	Pulmonary Embolism 01/2012
1	Cognitive Dysfunction 03/2010
1	Necrosis 02/2009
1	Heart Arrest (Cardiac Arrest) 10/2007
1	Hypotension (Low Blood Pressure) 10/2007
1	Cardiac Arrhythmias (Arrythmia) 02/2005

Drug/Important Bio-Agent (IBA)

14	Pravastatin (Pravachol)FDA LinkGeneric 11/2017 - 09/2008
10	IvabradineIBA 02/2016 - 10/2009
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2014 - 11/2005
6	LDL CholesterolIBA 11/2017 - 09/2008
5	oxidized low density lipoproteinIBA 11/2017 - 09/2008
4	IronIBA 12/2021 - 01/2020
4	LipidsIBA 07/2014 - 09/2008
3	CholesterolIBA 04/2015 - 01/2010
3	LDL Lipoproteins (beta Lipoproteins)IBA 02/2012 - 09/2008
2	C-Reactive ProteinIBA 11/2021 - 03/2010
2	Biomarkers (Surrogate Marker)IBA 11/2020 - 05/2010
2	Thrombin FDA Link 08/2015 - 03/2010
2	KinesinsIBA 02/2012 - 01/2011
2	Lipoproteins (Lipoprotein)IBA 02/2011 - 05/2010
2	Carvedilol (Coreg)FDA LinkGeneric 10/2007 - 02/2005
1	Hemoglobins (Hemoglobin)IBA 11/2021
1	Serum AlbuminIBA 11/2021
1	Uric Acid (Urate)IBA 11/2020
1	Allopurinol (Remid)FDA LinkGeneric 11/2020
1	Febuxostat FDA Link 11/2020
1	CreatinineIBA 04/2015
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 07/2014
1	type 2 taste receptorsIBA 02/2012
1	R-SNARE Proteins (Vesicle-Associated Membrane Protein)IBA 02/2012
1	Proteins (Proteins, Gene)FDA Link 02/2012
1	Lipoprotein(a)IBA 02/2012
1	Warfarin (Coumadin)FDA LinkGeneric 02/2011
1	Atorvastatin (Lipitor)FDA Link 01/2011
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 05/2010
1	Hemostatics (Antihemorrhagics)IBA 03/2010
1	fibrin fragment D (D-dimer)IBA 03/2010
1	Prothrombin (Factor II)IBA 03/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2009
1	Triglycerides (Triacylglycerol)IBA 02/2009
1	Interleukin-18 (Interleukin 18)IBA 02/2009
1	AdiponectinIBA 02/2009
1	AdipokinesIBA 02/2009
1	InterleukinsIBA 02/2009
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 09/2008
1	LDL Receptors (LDL Receptor)IBA 09/2008
1	Proprotein Convertase 9IBA 09/2008
1	Untranslated Regions (Untranslated Region)IBA 09/2008
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2005
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 02/2005

Therapy/Procedure

13	Therapeutics 11/2021 - 10/2007
5	Cardiac Resynchronization Therapy 01/2018 - 01/2016
3	Renal Dialysis (Hemodialysis) 11/2021 - 01/2020
1	Percutaneous Coronary Intervention 01/2021
1	Catheters 01/2020
1	Vagus Nerve Stimulation 01/2016
1	Activities of Daily Living (ADL) 03/2010